Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV)

被引：0

作者：

Gobert, A. ^{[1
]}

Veyri, M. ^{[1
]}

Lavole, A. ^{[2
]}

Montaudie, H. ^{[3
]}

Cloarec, N. ^{[4
]}

Doucet, L. ^{[5
]}

Gounant, V. ^{[6
]}

Massiani, M-A. ^{[7
]}

Helissey, C. ^{[8
]}

Bregigeon, S. ^{[9
]}

Chouaid, C. ^{[10
]}

Poulet, C-H. ^{[11
]}

Dewolf, M. ^{[12
]}

Kerjouan, M. ^{[13
]}

Beaucaire-Danel, S. ^{[14
]}

Brosseau, S. ^{[15
]}

Le Garff, G. ^{[16
]}

Garrait, V. ^{[17
]}

Marcelin, A-G. ^{[18
]}

Spano, J-P. ^{[1
]}

机构：

[1] Grp Hosp Pitie Salpetriere, Med Oncol, Paris, France

[2] Hosp Tenon, AP HP, Pneumol, Paris, France

[3] Nice Univ Hosp, Ctr Mediterraneen Med Mol, Dept Dermatol, INSERM,U1065, Nice, France

[4] CH Avignon, Hematol & Med Oncol, Avignon, France

[5] Hop St Louis, Med Oncol, Paris, France

[6] Hop Bichat Claude Bernard, Pneumol, Paris, France

[7] Inst Curie, Med Oncol, St Cloud, France

[8] Begin Mil Teaching Hosp, St Mande, France

[9] AP HM, Clin Immunol & Hematol Ctr, Marseille, France

[10] Ctr Hosp Intercommunal Creteil, Chest Dept, Creteil, France

[11] CHU Amiens Picardie Site Sud, Pneumol, Amiens, France

[12] CHU Reims, Pneumol, Reims, France

[13] CHU Rennes, Pneumol, Rennes, France

[14] Inst Curie, Dept Oncol, Paris, France

[15] Hop Bichat Claude Bernard, Pneumol, Paris, France

[16] CH St Brieuc, Pneumol, St Brieuc, France

[17] CHIC Creteil, Trop & Infect Dis Dept, Creteil, France

[18] Grp Hosp Pitie Salpetriere, Virol, Paris, France

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1213P_PR

引用

页码：733 / 733

页数：1

共 50 条

[21] The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseases
Wu, Chunlan
Zhong, Li
Wu, Qing
Lin, Shaowei
Xie, Xianhe
IMMUNOTHERAPY, 2021, 13 (06) : 527 - 540
[22] Economic analyses of immune-checkpoint inhibitors to treat lung cancer
Vergnenegre, Alain
Chouaid, Christos
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 365 - 371
[23] CLOSTRIDIOIDES DIFFICILE INFECTIONS IN CANCER PATIENTS ON IMMUNE-CHECKPOINT INHIBITORS
Vasavada, Shaleen
Amin, Rajan
Okhuysen, Pablo C.
Thomas, Anusha Shirwaikar
Wang, Yinghong
GASTROENTEROLOGY, 2021, 160 (06) : S50 - S51
[24] Immune-mediated adverse effects of immune-checkpoint inhibitors and their management in cancer
Jin, Ke-Tao
Wang, Shi-Bing
Ying, Xiao-Jiang
Lan, Huan-Rong
Lv, Jie-Qing
Zhang, Li-Hua
Motallebnezhad, Morteza
Mou, Xiao-Zhou
IMMUNOLOGY LETTERS, 2020, 221 : 61 - 71
[25] Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review
D'Izarny-Gargas, Thibaut
Durrbach, Antoine
Zaidan, Mohamad
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (09) : 2457 - 2465
[26] Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer Living With HIV: A Perspective on Recent Progress and Future Needs
Sahin, Ibrahim Halil
Kane, Sujata R.
Brutcher, Edith
Guadagno, Jessica
Smith, Katherine E.
Wu, Christina
Lesinski, Gregory B.
Gunthel, Clifford J.
El-Rayes, Bassel F.
JCO ONCOLOGY PRACTICE, 2020, 16 (06) : 319 - +
[27] Adding immune-checkpoint inhibitors to chemotherapy extends survival in endometrial cancer
Diana Romero
Nature Reviews Clinical Oncology, 2023, 20 : 353 - 353
[28] Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
Queirolo, Paola
Boutros, Andrea
Tanda, Enrica
Spagnolo, Francesco
Quaglino, Pietro
SEMINARS IN CANCER BIOLOGY, 2019, 59 : 290 - 297
[29] Future directions in immune-checkpoint inhibitors in NSCLC
Hayashi, Hidetoshi
CANCER SCIENCE, 2018, 109 : 1225 - 1225
[30] Neurological toxicities associated with immune-checkpoint inhibitors
Touat, Mehdi
Talmasov, Daniel
Ricard, Damien
Psimaras, Dimitri
CURRENT OPINION IN NEUROLOGY, 2017, 30 (06) : 659 - 668

← 1 2 3 4 5 →